176 related articles for article (PubMed ID: 7486402)
1. Pharmacokinetics of enrofloxacin in clinically normal dogs and mice and drug pharmacodynamics in neutropenic mice with Escherichia coli and staphylococcal infections.
Meinen JB; McClure JT; Rosin E
Am J Vet Res; 1995 Sep; 56(9):1219-24. PubMed ID: 7486402
[TBL] [Abstract][Full Text] [Related]
2. Tissue distribution and disposition kinetics of enrofloxacin in healthy and E. coli infected broilers.
Soliman GA
Dtsch Tierarztl Wochenschr; 2000 Jan; 107(1):23-7. PubMed ID: 10689795
[TBL] [Abstract][Full Text] [Related]
3. Comparison of amikacin dosing regimens in neutropenic guinea pigs with Escherichia coli infection.
McClure JT; Rosin E
Am J Vet Res; 1998 Jun; 59(6):750-5. PubMed ID: 9622746
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of enrofloxacin in adult horses and concentration of the drug in serum, body fluids, and endometrial tissues after repeated intragastrically administered doses.
Giguère S; Sweeney RW; Bélanger M
Am J Vet Res; 1996 Jul; 57(7):1025-30. PubMed ID: 8807015
[TBL] [Abstract][Full Text] [Related]
5. In vitro antibacterial activity of enrofloxacin and ciprofloxacin in combination against Escherichia coli and staphylococcal clinical isolates from dogs.
Lautzenhiser SJ; Fialkowski JP; Bjorling D; Rosin E
Res Vet Sci; 2001 Jun; 70(3):239-41. PubMed ID: 11676620
[TBL] [Abstract][Full Text] [Related]
6. Enrofloxacin concentrations in dogs with normal prostate and dogs with chronic bacterial prostatitis.
Dorfman M; Barsanti J; Budsberg SC
Am J Vet Res; 1995 Mar; 56(3):386-90. PubMed ID: 7771709
[TBL] [Abstract][Full Text] [Related]
7. Plasma concentrations of enrofloxacin and its active metabolite ciprofloxacin in dogs following single oral administration of enrofloxacin at 7.5, 10, or 20 mg/kg.
Boothe DM; Boeckh A; Boothe HW; Wilkie S; Jones S
Vet Ther; 2002; 3(4):409-19. PubMed ID: 12584678
[TBL] [Abstract][Full Text] [Related]
8. Cortical bone concentrations of enrofloxacin in dogs.
Duval JM; Budsberg SC
Am J Vet Res; 1995 Feb; 56(2):188-92. PubMed ID: 7717584
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic evaluation of enrofloxacin administered orally to healthy dogs.
Walker RD; Stein GE; Hauptman JG; MacDonald KH
Am J Vet Res; 1992 Dec; 53(12):2315-9. PubMed ID: 1335707
[TBL] [Abstract][Full Text] [Related]
10. Determination of skin concentrations of enrofloxacin in dogs with pyoderma.
DeManuelle TC; Ihrke PJ; Brandt CM; Kass PH; Vulliet PR
Am J Vet Res; 1998 Dec; 59(12):1599-604. PubMed ID: 9858413
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic variables and tissue residues of enrofloxacin and ciprofloxacin in healthy pigs.
Anadón A; Martínez-Larrañaga MR; Díaz MJ; Fernández-Cruz ML; Martínez MA; Frejo MT; Martínez M; Iturbe J; Tafur M
Am J Vet Res; 1999 Nov; 60(11):1377-82. PubMed ID: 10566812
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics/pharmacodynamics of antofloxacin hydrochloride in a neutropenic murine thigh model of Staphylococcus aureus infection.
Xiao XM; Xiao YH
Acta Pharmacol Sin; 2008 Oct; 29(10):1253-60. PubMed ID: 18817632
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of a single intravenous enrofloxacin dose in scimitar-horned oryx (Oryx dammah).
Gamble KC; Boothe DM; Jensen JM; Heatley JJ; Helmick KE
J Zoo Wildl Med; 1997 Mar; 28(1):36-42. PubMed ID: 9226614
[TBL] [Abstract][Full Text] [Related]
14. Serum concentrations and pharmacokinetics of enrofloxacin after intravenous and intragastric administration to mares.
Haines GR; Brown MP; Gronwall RR; Merritt KA
Can J Vet Res; 2000 Jul; 64(3):171-7. PubMed ID: 10935883
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and intramuscular administrations in sheep.
Mengozzi G; Intorre L; Bertini S; Soldani G
Am J Vet Res; 1996 Jul; 57(7):1040-3. PubMed ID: 8807018
[TBL] [Abstract][Full Text] [Related]
16. Comparative pharmacokinetics of enrofloxacin in mice, rats, rabbits, sheep, and cows.
Bregante MA; Saez P; Aramayona JJ; Fraile L; Garcia MA; Solans C
Am J Vet Res; 1999 Sep; 60(9):1111-6. PubMed ID: 10490081
[TBL] [Abstract][Full Text] [Related]
17. The effect of endotoxin and dexamethasone on enrofloxacin pharmacokinetic parameters in swine.
Post LO; Farrell DE; Cope CV; Baker JD; Myers MJ
J Pharmacol Exp Ther; 2003 Feb; 304(2):889-95. PubMed ID: 12538847
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of canine and feline Escherichia coli and canine Staphylococcus intermedius isolates to fluoroquinolones.
Gottlieb S; Wigney DI; Martin PA; Norris JM; Malik R; Govendir M
Aust Vet J; 2008 Apr; 86(4):147-52. PubMed ID: 18363989
[TBL] [Abstract][Full Text] [Related]
19. Bacterial killing by use of once daily gentamicin dosage in guinea pigs with Escherichia coli infection.
Campbell BG; Bartholow S; Rosin E
Am J Vet Res; 1996 Nov; 57(11):1627-30. PubMed ID: 8915442
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in goats given enrofloxacin alone and in combination with probenecid.
Rao GS; Ramesh S; Ahmad AH; Tripathi HC; Sharma LD; Malik JK
Vet J; 2002 Jan; 163(1):85-93. PubMed ID: 11749141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
